MC 139 L-Aspartic acid, [14C(U)]- Click here for Typical Certificate of Analysis |
|
| HOOCCH2CH(NH2)COOH | |
|
MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram |
|
| Ethanol:water (2:98) solution, 100 µCi/ml | |
| > 130 mCi(4.81 GBq)/mmol | 50 µCi (1.85 MBq) $3970 |
| NextGen V-Vial | |
| M.W. 133.10 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 139H L-Aspartic acid, [14C(U)]- |
|
| HOOCCH2CH(NH2)COOH | |
|
MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram |
|
| Ethanol:water (2:98) solution, 100 µCi/ml | |
| > 200 mCi(7.4 GBq)/mmol | 50 µCi (1.85 MBq) $3970 |
| NextGen V-Vial | |
| M.W. 133.10 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1747 2-Methyl-D,L-aspartic acid, disodium salt, [3H]- |
|
| Click here for Typical Certificate of Analysis | |
| HOOCCH2C(CH3)(NH2)COOH | |
|
|
|
| Ethanol:water (2:98) solution, 1 mCi/ml | 50 μCi (1.85 MBq) $1160 |
| > 0.25 Ci(9.25 GBq)/mmol | 250 μCi (9.25 MBq) $1970 |
| NextGen V-Vial | |
| M.W. 191.09 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |